PeLeMed
Yeoksamdong
About PeLeMed
PeLeMed is a drug development company working on the discovery of anti-cancer drugs. The company's innovative therapeutic candidates through type 1 kinase inhibitor development platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2023)
- Website: pelemed.com
- Phone: 822-965-7977
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/pelemed-21725 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.